Business Context and Reporting Period
This Form 8-K Current Report was filed by Aspen Insurance Holdings Limited on February 6, 2009, covering events occurring on February 2, 2009, and February 3, 2009. The filing primarily addresses corporate governance changes, specifically the departure of a director and executive compensation adjustments.
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to specific executive compensation packages approved by the Compensation Committee.
| Executive Officer | 2009 Salary (Effective April 1, 2009) | 2008 Bonus |
|---|---|---|
| Christopher O'Kane (CEO) | $695,568 | $0 |
| Richard Houghton (CFO) | $521,676 | $0 |
| Julian Cusack (COO) | $521,676 | $0 |
| Brian Boornazian (Head of Reinsurance) | $500,000 | $245,000 |
| James Few (Head of Property Reinsurance) | $475,000 | $205,000 |
Note: Salaries for O'Kane, Houghton, and Cusack are paid in British Pounds and converted to USD at a rate of $1.4491 to £1.
Material Changes
- Director Departure: Dr. Norman Rosenthal will not stand for re-election as a director at the Annual General Meeting on April 29, 2009, and will cease to serve as a director on that date.
- Executive Compensation: The Compensation Committee approved salary increases for the CEO, CFO, and COO effective April 1, 2009. Additionally, bonuses were awarded to Brian Boornazian and James Few for the 2008 performance year.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. Regarding Dr. Rosenthal's departure, the Compensation Committee agreed to accelerate the vesting of any unvested portions of previously awarded equity on April 29, 2009. Dr. Rosenthal will have one year from that date to exercise his options. Unvested restricted share units will vest according to their terms, with the final tranche vesting on April 29, 2009.
The filing notes that Stuart Sinclair, Former Chief Operating Officer, resigned on March 17, 2008, and is serving the remainder of his notice period on garden leave.
Investor Verification Checklist
- Verify the exact terms of Dr. Norman Rosenthal's equity vesting acceleration and option exercise window.
- Confirm the currency conversion rate used for executive salaries in future filings to ensure accurate USD reporting.
- Review the upcoming Form 10-K for detailed compensation tables for Named Executive Officers for the year ended December 31, 2008.
- Monitor the April 29, 2009 Annual General Meeting for the official ratification of the board composition changes.